Bovine TB and Johne’s Disease are two devastating livestock diseases. PBD Biotech’s diagnostic Actiphage® is an accurate and specific blood test for these diseases.
Hear about development of an improved diagnostic for bTB and Johne’s Disease on 6th July
PBD Biotech gains £2.3m funding to take Actiphage through to OIE validation, a requirement for international adoption of this diagnostic for mycobacterial diseases including bTB, Johne’s Disease and human TB
Johne’s disease costs the Canadian dairy industry an estimated $90 million a year through loss of production. PBD Biotech has gained funding from the Canadian government to progress development of its unique Actiphage test for mycobacterial diseases to address this major economic issue.